EMC, NetApp battle for Data Domain acquisition

Justine Varieur Cadet | | Health Imaging | Artificial Intelligence
EMC Monday offered to purchase data-storage developer Data Domain for $1.8 billion in cash, surpassing its rival NetApp's previous offer of $1.5 billion in stock and cash. Data Domain has yet to accept either offer.

The Santa Clara, Calif.-based Data Domain makes deduplication storage systems. At the time of its offer, the Sunnyvale, Calif.-based NetApp said that Data Domain's portfolio would expand its reach in the market for heterogeneous disk-based backup.

NetApp said it intends to operate Data Domain as a product line within its product operations organization. Also, the Data Domain sales organization would be integrated with NetApp's sales force.

The Hopkinton, Mass.-based EMC said its all-cash proposal is not subject to a financing or due diligence contingency. EMC said it will use existing cash balances to finance the transaction.

EMC warned Data Domain that because its offer is identical to the offer of NetApp in all aspects other than the increase in price, Data Domain's board of directors would risk breaching its fiduciary duties to its shareholders.

In order to speed acceptance of their offer, EMC said it is waiving its right to review Data Domain financial data; in addition, the firm stated that Data Domain does not need to enter into discussions or negotiations with EMC or sign any confidentiality agreements with it.


Justine Varieur Cadet

Related Content

Experts developing AI model that learns from calcium-scoring CT scans
FDA has approved over 1,000 clinical AI applications, with most aimed at radiology
Commercially available AI increases breast cancer detection by nearly 20%
Clinicians want AI to show its work
ACR Assess-AI national data registry tracks performance of clinical algorithms
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.